Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Combination percutaneous and intraarterial therapy for the treatment of hepatocellular carcinoma: a review.

Carmi L, Georgiades C.

Semin Intervent Radiol. 2010 Sep;27(3):296-301. doi: 10.1055/s-0030-1261788.

2.

Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.

Li L, Tian J, Liu P, Wang X, Zhu Z.

Tumori. 2016 Jun 2;2016(3):301-10. doi: 10.5301/tj.5000491. Epub 2016 Mar 22.

PMID:
27002950
3.

Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).

Iezzi R, Cesario V, Siciliani L, Campanale M, De Gaetano AM, Siciliano M, Agnes S, Giuliante F, Grieco A, Pompili M, Rapaccini GL, Gasbarrini A, Bonomo L; HepatoCATT Group for the Multidisciplinary Management of HCC..

Radiol Med. 2013 Jun;118(4):555-69. doi: 10.1007/s11547-012-0914-7. Epub 2013 Jan 28.

PMID:
23358819
4.

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Poon RT, Fan ST, Tsang FH, Wong J.

Ann Surg. 2002 Apr;235(4):466-86. Review.

5.

Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.

Wang W, Shi J, Xie WF.

Liver Int. 2010 May;30(5):741-9. doi: 10.1111/j.1478-3231.2010.02221.x. Epub 2010 Mar 18.

PMID:
20331507
6.

[Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].

Fan WZ, Yang JY, Lü MD, Xie XY, Yin XY, Huang YH, Kuang M, Li HP, Xu HX, Li JP.

Zhonghua Yi Xue Za Zhi. 2011 Aug 23;91(31):2190-4. Chinese.

PMID:
22094036
7.

Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.

Xu RC, Liu HC, Li JL, Li K, Ou SY, Yu ZY, Kong Y, Ma GA, Shao WS.

Curr Med Res Opin. 2015 Aug;31(8):1553-60. doi: 10.1185/03007995.2015.1058249. Epub 2015 Jul 9.

PMID:
26067770
8.

Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.

Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M.

World J Gastroenterol. 2013 Sep 14;19(34):5622-32. doi: 10.3748/wjg.v19.i34.5622.

9.

Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.

Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM.

Eur J Surg Oncol. 2005 May;31(4):331-47. Review.

PMID:
15837037
10.

Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma.

Kirikoshi H, Saito S, Yoneda M, Fujita K, Mawatari H, Uchiyama T, Higurashi T, Goto A, Takahashi H, Abe Y, Inamori M, Kobayashi N, Kubota K, Sakaguchi T, Ueno N, Nakajima A.

Hepatol Res. 2009 Jun;39(6):553-62. doi: 10.1111/j.1872-034X.2009.00490.x.

PMID:
19527484
11.

Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.

Huang ZM, Li W, Li S, Gao F, Zhou QM, Wu FM, He N, Pan CC, Xia JC, Wu PH, Zhao M.

J Immunother. 2013 Jun;36(5):287-93. doi: 10.1097/CJI.0b013e3182948452.

PMID:
23719239
12.
13.

[Radiological treatment of hepatocellular carcinoma in 2010].

Rode A.

Cancer Radiother. 2011 Feb;15(1):21-7. doi: 10.1016/j.canrad.2010.11.002. Epub 2011 Jan 22. Review. French.

PMID:
21257330
14.

Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center.

Bharadwaz A, Bak-Fredslund KP, Villadsen GE, Nielsen JE, Simonsen K, Sandahl TD, Grønbæk H, Nielsen DT.

Acta Radiol. 2016 Jul;57(7):844-51. doi: 10.1177/0284185115603246. Epub 2015 Sep 3.

PMID:
26342009
15.

Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.

Peng ZW, Chen MS.

Oncology. 2013;84 Suppl 1:40-3. doi: 10.1159/000345888. Epub 2013 Feb 20.

16.

Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma.

Azuma S, Asahina Y, Nishimura-Sakurai Y, Kakinuma S, Kaneko S, Nagata H, Goto F, Ootani S, Kawai-Kitahata F, Taniguchi M, Murakawa M, Watanabe T, Tasaka-Fujita M, Itsui Y, Nakagawa M, Watanabe M.

Hepatol Res. 2016 Apr;46(4):312-9. doi: 10.1111/hepr.12566. Epub 2015 Sep 15.

PMID:
26224167
17.

Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis.

Abdelaziz AO, Nabeel MM, Elbaz TM, Shousha HI, Hassan EM, Mahmoud SH, Rashed NA, Ibrahim MM, Abdelmaksoud AH.

Scand J Gastroenterol. 2015 Apr;50(4):479-84. doi: 10.3109/00365521.2014.1003397. Epub 2015 Jan 16.

PMID:
25592058
18.

Percutaneous therapies of hepatocellular carcinoma-an update.

Chapiro J, Geschwind JF.

Chin Clin Oncol. 2013 Dec;2(4):36. doi: 10.3978/j.issn.2304-3865.2013.07.04.

19.

Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.

Si Q, Mu H, Yan G, Qian X, Xu C, Wang X, Tong W.

Hepatogastroenterology. 2007 Mar;54(74):334-41.

PMID:
17523269

Supplemental Content

Support Center